Brinker Capital Investments LLC raised its position in Enhabit, Inc. (NYSE:EHAB – Get Rating) by 42.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,305 shares of the company’s stock after purchasing an additional 21,038 shares during the quarter. Brinker Capital Investments LLC owned 0.14% of Enhabit worth $925,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of EHAB. IFP Advisors Inc purchased a new stake in shares of Enhabit during the 3rd quarter valued at about $39,000. Bessemer Group Inc. purchased a new stake in shares of Enhabit during the 3rd quarter valued at about $26,000. Lazard Asset Management LLC purchased a new stake in shares of Enhabit during the 3rd quarter valued at about $34,000. South Dakota Investment Council purchased a new stake in shares of Enhabit during the 3rd quarter valued at about $45,000. Finally, KBC Group NV purchased a new stake in shares of Enhabit during the 3rd quarter valued at about $54,000. 95.55% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the company. Citigroup raised their target price on Enhabit from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, February 17th. Stifel Nicolaus raised their price objective on Enhabit from $17.00 to $18.00 in a research note on Wednesday, February 15th. The Goldman Sachs Group assumed coverage on Enhabit in a research note on Thursday, March 16th. They set a “neutral” rating and a $15.00 price objective for the company. Finally, Credit Suisse Group restated a “neutral” rating and set a $15.00 price objective on shares of Enhabit in a research note on Thursday, February 16th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Enhabit presently has an average rating of “Hold” and a consensus price target of $16.50.
Enhabit Trading Up 0.7 %
Enhabit (NYSE:EHAB – Get Rating) last issued its earnings results on Tuesday, February 14th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.25 by $0.07. The company had revenue of $275.10 million during the quarter, compared to analyst estimates of $268.15 million. Enhabit had a return on equity of 7.60% and a net margin of 5.77%. As a group, sell-side analysts expect that Enhabit, Inc. will post 0.71 EPS for the current year.
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
See Also
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Starbucks Stock Becomes a Value Play
- Kraft Heinz Recovery Gains Momentum
- Here’s Why AMD’s Weak Guidance Is A Blessing In Disguise
- BP Shares Sold Off After Earnings: Here Is What Upset Markets
- Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Get Rating).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.